Science & Research

Dr. Eliaz and his team partner with renowned institutes including Harvard, Columbia, and others to investigate integrative approaches in the treatment of cancer and chronic conditions. In addition, many of Dr. Eliaz’s unique preparations have been studied independently by third-party groups, with peer-reviewed results demonstrating unparalleled benefits against cancer, fibrotic diseases and more.

The unique form of Modified Citrus Pectin developed by Dr. Eliaz is recognized as the only commercially available galectin-3 blocker, substantiated by more than 40 published studies in cancer, cardiovascular disease, chronic kidney disease, and other pro-inflammatory, degenerative conditions.

This website is provided for informational purposes only and is not intended as a substitute for the advice provided by your physician or other healthcare professional. You should not use the information on this website for diagnosing or treating a health problem or disease, prescribing any medication or other treatment, or discontinuing any medication or treatment recommended by your healthcare provider.